The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation

Kidney International

Volumn 68, Issue 5, 2005, Pages 2345-2351

  Gill, John S ^a   Tonelli, Marcello ^b   Johnson, Nathan ^b   Kiberd, Bryce ^b   Landsberg, David ^b   Pereira, Brian J G ^b  

^a ST PAUL S HOSPITAL   (Canada)

^b NONE

Author keywords

Comorbid conditions; Kidney transplantation; Patient survival; Waiting time

Indexed keywords

ADULT; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; DEATH; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SURVIVAL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; TIME FACTORS; WAITING LISTS;

EID: 30944464626     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00696.x     Document Type: Conference Paper

References (16)

1. WOLFE R, ASHBY V, MILFORD E, et al: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341:1725-1730, 1999
2. LAUPACIS A, KEOWN P, PUS N, et al: A study of the quality of life and cost-utility of renal transplantation. Kidney Int 50:235-242, 1996
3. WINKELMAYER WC, WEINSTEIN MC, MITTLEMAN MA, et al: Health economic evaluations: The special case of end-stage renal disease treatment. Med Decis Making 22:417-430, 2002
4. UNITED NETWORK OF ORGAN SHARING: Available at: http://www.unos.org
5. XUE JL, MA JZ, LOUIS TA, COLLINS AJ: Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 12:2753-2758, 2001
6. DANOVITCH GM, HARIHARAN S, PIRSCH JD, et al: Management of the waiting list for cadaveric kidney transplants: Report of a survey and recommendations by the clinical practice guidelines committee of the american society of transplantation. J Am Soc Nephrol 13:528-535, 2002
7. UNITED STATES RENAL DATA SYSTEM: USRDS 2003 Annual Data Report: Atlas of End Stage Renal Disease in the United States, Bethesda, MD, National Institues of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003
8. ALLISON PD: Survival Analysis Using the SAS System: A Practical Guide, Cary, NC, SAS Institute Incorporated, 2000
9. FOLEY R, PARFREY P, SARNAK M: Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis 32(Suppl 3):S112-S119, 1998
10. LEVEY A, BETO J, CORONADO B, et al: Controlling the epidemic of cardiovascular diseasein chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 32:853-906, 1998
11. KASISKE BL, GUIJARRO C, MASSY ZA, et al: Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7:158-165, 1996
12. KASISKE BL, VAZQUEZ MA, HARMON WE, et al: Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 11(Suppl 15):S1-86, 2000
13. COSIO FG, ALAMIR A, YIM S, et al: Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Kidney Int 53:767-772, 1998
14. MEIER-KRIESCHE HU, PORT FK, OJO AO, et al: Effect of waiting time on renal transplant outcome. Kidney Int 58:1311-1317, 2000
15. MEIER-KRIESCHE HU, SCHOLD JD, KAPLAN B: Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 4:1289-1295, 2004
16. WOLFE RA: Long-term renal allograft survival: A cup both half-full and half-empty. Am J Transplant 4:1215-1216, 2004